ParkinsonCanadaV1, PascalFrancis, Corpus, bibRecord, 000287

Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations

Identifieur interne : 000287 ( PascalFrancis/Corpus ); précédent : 000286; suivant : 000288

Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations

Auteurs : Jennifer G. Goldman ; Darcy Marr ; LILI ZHOU ; Bichun Ouyang ; Sue E. Leurgans ; Elizabeth Berry-Kravis ; Christopher G. Goetz

Source :

Movement disorders [ 0885-3185 ] ; 2011.

RBID : Pascal:11-0379833

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Hallucination, Pathologie du système nerveux, Cholécystokinine, Polymorphisme.

English descriptors

KwdEn :
- Cholecystokinin, Hallucination, Nervous system diseases, Parkinson disease, Polymorphism.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 26`
A06				`@2 9`
A08	`01`	`1`	`ENG`	`@1 Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations`
A11	`01`	`1`		`@1 GOLDMAN (Jennifer G.)`
A11	`02`	`1`		`@1 MARR (Darcy)`
A11	`03`	`1`		`@1 LILI ZHOU`
A11	`04`	`1`		`@1 OUYANG (Bichun)`
A11	`05`	`1`		`@1 LEURGANS (Sue E.)`
A11	`06`	`1`		`@1 BERRY-KRAVIS (Elizabeth)`
A11	`07`	`1`		`@1 GOETZ (Christopher G.)`
A14	`01`			`@1 Department of Neurological Sciences, Rush University Medical Center @2 Chicago, Illinois @3 USA @Z 1 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut.`
A14	`02`			`@1 University of British Columbia @2 Vancouver, British Columbia @3 CAN @Z 2 aut.`
A14	`03`			`@1 Department of Pediatrics, Rush University Medical Center @2 Chicago, Illinois @3 USA @Z 3 aut. @Z 6 aut.`
A14	`04`			`@1 Department of Preventive Medicine, Rush University Medical Center @2 Chicago, Illinois @3 USA @Z 5 aut.`
A14	`05`			`@1 Department of Biochemistry, Rush University Medical Center @2 Chicago, Illinois @3 USA @Z 6 aut.`
A20				`@1 1781-1782`
A21				`@1 2011`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000508939410420`
A44				`@0 0000 @1 © 2011 INIST-CNRS. All rights reserved.`
A45				`@0 7 ref.`
A47	`01`	`1`		`@0 11-0379833`
A60				`@1 P @3 CR`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Hallucination @5 02`
C03	`02`	`X`	`ENG`	`@0 Hallucination @5 02`
C03	`02`	`X`	`SPA`	`@0 Alucinación @5 02`
C03	`03`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 03`
C03	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 03`
C03	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 03`
C03	`04`	`X`	`FRE`	`@0 Cholécystokinine @5 09`
C03	`04`	`X`	`ENG`	`@0 Cholecystokinin @5 09`
C03	`04`	`X`	`SPA`	`@0 Colecistoquinina @5 09`
C03	`05`	`X`	`FRE`	`@0 Polymorphisme @5 10`
C03	`05`	`X`	`ENG`	`@0 Polymorphism @5 10`
C03	`05`	`X`	`SPA`	`@0 Polimorfismo @5 10`
C07	`01`	`X`	`FRE`	`@0 Neuropeptide @5 37`
C07	`01`	`X`	`ENG`	`@0 Neuropeptide @5 37`
C07	`01`	`X`	`SPA`	`@0 Neuropéptido @5 37`
C07	`02`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 38`
C07	`02`	`X`	`ENG`	`@0 Cerebral disorder @5 38`
C07	`02`	`X`	`SPA`	`@0 Encéfalo patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 39`
C07	`03`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 39`
C07	`03`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 39`
C07	`04`	`X`	`FRE`	`@0 Maladie dégénérative @5 40`
C07	`04`	`X`	`ENG`	`@0 Degenerative disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 40`
C07	`05`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 41`
C07	`05`	`X`	`ENG`	`@0 Central nervous system disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 41`
N21				`@1 262`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 11-0379833 INIST
ET :	Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations
AU :	GOLDMAN (Jennifer G.); MARR (Darcy); LILI ZHOU; OUYANG (Bichun); LEURGANS (Sue E.); BERRY-KRAVIS (Elizabeth); GOETZ (Christopher G.)
AF :	Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis (1 aut., 4 aut., 5 aut., 6 aut., 7 aut.); University of British Columbia/Vancouver, British Columbia/Canada (2 aut.); Department of Pediatrics, Rush University Medical Center/Chicago, Illinois/Etats-Unis (3 aut., 6 aut.); Department of Preventive Medicine, Rush University Medical Center/Chicago, Illinois/Etats-Unis (5 aut.); Department of Biochemistry, Rush University Medical Center/Chicago, Illinois/Etats-Unis (6 aut.)
DT :	Publication en série; Correspondance, lettre; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 9; Pp. 1781-1782; Bibl. 7 ref.
LA :	Anglais
CC :	002B17; 002B17G
FD :	Maladie de Parkinson; Hallucination; Pathologie du système nerveux; Cholécystokinine; Polymorphisme
FG :	Neuropeptide; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central
ED :	Parkinson disease; Hallucination; Nervous system diseases; Cholecystokinin; Polymorphism
EG :	Neuropeptide; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD :	Parkinson enfermedad; Alucinación; Sistema nervioso patología; Colecistoquinina; Polimorfismo
LO :	INIST-20953.354000508939410420
ID :	11-0379833

Links to Exploration step

Pascal:11-0379833

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations</title>
<author><name sortKey="Goldman, Jennifer G" sort="Goldman, Jennifer G" uniqKey="Goldman J" first="Jennifer G." last="Goldman">Jennifer G. Goldman</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Marr, Darcy" sort="Marr, Darcy" uniqKey="Marr D" first="Darcy" last="Marr">Darcy Marr</name>
<affiliation><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lili Zhou" sort="Lili Zhou" uniqKey="Lili Zhou" last="Lili Zhou">LILI ZHOU</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Pediatrics, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ouyang, Bichun" sort="Ouyang, Bichun" uniqKey="Ouyang B" first="Bichun" last="Ouyang">Bichun Ouyang</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leurgans, Sue E" sort="Leurgans, Sue E" uniqKey="Leurgans S" first="Sue E." last="Leurgans">Sue E. Leurgans</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Department of Preventive Medicine, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Berry Kravis, Elizabeth" sort="Berry Kravis, Elizabeth" uniqKey="Berry Kravis E" first="Elizabeth" last="Berry-Kravis">Elizabeth Berry-Kravis</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Pediatrics, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Department of Biochemistry, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0379833</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0379833 INIST</idno>
<idno type="RBID">Pascal:11-0379833</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000287</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations</title>
<author><name sortKey="Goldman, Jennifer G" sort="Goldman, Jennifer G" uniqKey="Goldman J" first="Jennifer G." last="Goldman">Jennifer G. Goldman</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Marr, Darcy" sort="Marr, Darcy" uniqKey="Marr D" first="Darcy" last="Marr">Darcy Marr</name>
<affiliation><inist:fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lili Zhou" sort="Lili Zhou" uniqKey="Lili Zhou" last="Lili Zhou">LILI ZHOU</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Pediatrics, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ouyang, Bichun" sort="Ouyang, Bichun" uniqKey="Ouyang B" first="Bichun" last="Ouyang">Bichun Ouyang</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leurgans, Sue E" sort="Leurgans, Sue E" uniqKey="Leurgans S" first="Sue E." last="Leurgans">Sue E. Leurgans</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Department of Preventive Medicine, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Berry Kravis, Elizabeth" sort="Berry Kravis, Elizabeth" uniqKey="Berry Kravis E" first="Elizabeth" last="Berry-Kravis">Elizabeth Berry-Kravis</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Pediatrics, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Department of Biochemistry, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cholecystokinin</term>
<term>Hallucination</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Polymorphism</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Hallucination</term>
<term>Pathologie du   système nerveux</term>
<term>Cholécystokinine</term>
<term>Polymorphisme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>26</s2>
</fA05>
<fA06><s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GOLDMAN (Jennifer G.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MARR (Darcy)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>LILI ZHOU</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>OUYANG (Bichun)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LEURGANS (Sue E.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>BERRY-KRAVIS (Elizabeth)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>GOETZ (Christopher G.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>University of British Columbia</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Pediatrics, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Preventive Medicine, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Biochemistry, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20><s1>1781-1782</s1>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000508939410420</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>7 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>11-0379833</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CR</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Hallucination</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Hallucination</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Alucinación</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Cholécystokinine</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cholecystokinin</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Colecistoquinina</s0>
<s5>09</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Polymorphisme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Polymorphism</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Polimorfismo</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Neuropeptide</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Neuropeptide</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Neuropéptido</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>262</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 11-0379833 INIST</NO>
<ET>Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations</ET>
<AU>GOLDMAN (Jennifer G.); MARR (Darcy); LILI ZHOU; OUYANG (Bichun); LEURGANS (Sue E.); BERRY-KRAVIS (Elizabeth); GOETZ (Christopher G.)</AU>
<AF>Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis (1 aut., 4 aut., 5 aut., 6 aut., 7 aut.); University of British Columbia/Vancouver, British Columbia/Canada (2 aut.); Department of Pediatrics, Rush University Medical Center/Chicago, Illinois/Etats-Unis (3 aut., 6 aut.); Department of Preventive Medicine, Rush University Medical Center/Chicago, Illinois/Etats-Unis (5 aut.); Department of Biochemistry, Rush University Medical Center/Chicago, Illinois/Etats-Unis (6 aut.)</AF>
<DT>Publication en série; Correspondance, lettre; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 9; Pp. 1781-1782; Bibl. 7 ref.</SO>
<LA>Anglais</LA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Hallucination; Pathologie du   système nerveux; Cholécystokinine; Polymorphisme</FD>
<FG>Neuropeptide; Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du   système nerveux central</FG>
<ED>Parkinson disease; Hallucination; Nervous system diseases; Cholecystokinin; Polymorphism</ED>
<EG>Neuropeptide; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Parkinson enfermedad; Alucinación; Sistema nervioso patología; Colecistoquinina; Polimorfismo</SD>
<LO>INIST-20953.354000508939410420</LO>
<ID>11-0379833</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000287 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000287 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0379833
   |texte=   Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations

Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations

Source :

Descripteurs français

English descriptors

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri